1. Home
  2. RDNT vs SRRK Comparison

RDNT vs SRRK Comparison

Compare RDNT & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RadNet Inc.

RDNT

RadNet Inc.

N/A

Current Price

$69.96

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

N/A

Current Price

$48.36

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RDNT
SRRK
Founded
1985
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.2B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
RDNT
SRRK
Price
$69.96
$48.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
18
Target Price
★ $97.00
$70.06
AVG Volume (30 Days)
700.0K
★ 1.5M
Earning Date
11-08-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $1,616,630,000.00
N/A
Revenue This Year
$23.26
N/A
Revenue Next Year
$13.17
$662.10
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 13.05
N/A
52 Week Low
$50.82
$38.69
52 Week High
$85.84
$61.76

Technical Indicators

Market Signals
Indicator
RDNT
SRRK
Relative Strength Index (RSI) 39.28 56.01
Support Level $67.52 $44.88
Resistance Level $72.80 $50.56
Average True Range (ATR) 3.60 2.95
MACD -0.92 0.48
Stochastic Oscillator 12.33 57.77

Price Performance

Historical Comparison
RDNT
SRRK

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: